In Vivo Drug Combination Screening Services
Drug Combination Services
In Vivo Drug Combination Screening Services Overview
The fight against cancer is a complex battle, and it often requires a multifaceted approach. One of the most promising strategies in recent years is combination therapy. This approach involves using multiple drugs simultaneously to target different aspects of tumor growth and survival. The advantage of combination therapy lies in its potential to overcome drug resistance, enhance therapeutic efficacy, and reduce side effects.
Our In Vivo Drug Combination Screening Workflow
Our systematic In Vivo drug combination screening process ensures accurate and reproducible results. The workflow follows a structured approach tailored to specific therapeutic objectives:
- Study Design Consultation – Defining experimental goals and selecting the most suitable in vivo models.
- Model Selection – Using well-characterized models, including xenograft and syngeneic systems, to reflect disease progression.
- Dosing Strategy Development – Optimizing drug administration sequences and concentration levels.
- In Vivo Treatment and Monitoring – Assessing tumor response, survival rates, and biomarker changes.
- Data Collection & Analysis – Evaluating synergy or antagonism using combination index models and statistical methods.
- Comprehensive Reporting – Delivering a detailed study report with raw data, interpretation, and potential clinical implications.
Each study is customized to meet specific research requirements, ensuring translational relevance and high-quality data.
Advantages of Our In Vivo Screening Services
Our in vivo drug combination screening platform provides scientifically validated insights that contribute to drug development and clinical translation. Key advantages include:
✔ Identification of Synergistic Drug Combinations – Determining drug pairings that improve efficacy beyond individual treatments.
✔ Overcoming Drug Resistance – Understanding mechanisms that lead to resistance and exploring potential solutions.
✔ Preclinical Validation of Therapeutic Strategies – Assessing efficacy and toxicity in a controlled biological environment.
✔ Comprehensive Pharmacodynamic and Pharmacokinetic Data – Generating detailed profiles for regulatory and clinical applications.
✔ High-Quality, Reproducible Data – Ensuring consistency across studies through rigorous validation protocols.
Customized In Vivo Drug Screening Solutions
Recognizing that every research project has unique objectives, we offer tailored in vivo screening solutions:
- Model Adaptation – Selection of xenograft, syngeneic, or custom-engineered disease models.
- Flexible Dosing Regimens – Optimizing drug exposure schedules for maximum therapeutic effect.
- Biomarker Integration – Incorporating molecular readouts to assess treatment response.
- Mechanistic Studies – Investigating signaling pathways and immune responses to combination therapy.
- Translational Research Support – Bridging preclinical findings with potential clinical applications.
Our team collaborates with researchers to develop precisely tailored study designs, ensuring that experimental conditions reflect real-world clinical challenges.
Expert Support Throughout Your Project
From study design to data interpretation, our experienced team provides comprehensive support at every stage:
- Pre-Study Consultation – Assistance in designing protocols aligned with research objectives.
- Real-Time Data Monitoring – Continuous assessment of study progress for timely adjustments.
- Troubleshooting and Optimization – Addressing technical challenges to ensure successful execution.
- Post-Study Analysis – Detailed discussions of findings and their potential implications in drug development.
We understand the complexities of in vivo combination screening and work closely with researchers to deliver high-quality, interpretable results.
Start Your In Vivo Drug Combination Research with Kyinno
Advance your in vivo drug combination research with KYinno in three simple steps:
- Schedule a consultation
- Receive a customized study proposal
- Obtain high-quality, data-driven insights.
Our validated models and rigorous methodologies ensure reproducible results for assessing drug synergy, resistance mechanisms, and therapeutic efficacy. Contact us today to explore how our in vivo screening services can support your research.
Scientific Resources & Case Studies
In our latest research, we’ve explored the combined use of EGFR and MET inhibitors. These kinase inhibitors work by blocking the activity of their respective proteins, thereby halting tumor growth. However, cancer cells can become resistant to these drugs when used individually. By using them in combination, we aim to overcome this resistance and enhance anti-tumor effects.
EGFR inhibitors bring great benefits to lung cancer patients. However, one of the resistant mechanisms for EGFR inhibitors is met signaling over-activation. We constructed a met signaling over activation cell model by overexpression of HGF in the NCI-H1975 cell line.
Both in vitro and in vivo studies show neither EGFR inhibitor AZD9291 nor MET inhibitor AZD6094 can inhibit tumor growth. Interestingly, combined treatment with AZD9291 and AZD6094 indicates their synergy effect on tumor growth.
All Drug Combination Services
In vivo combination studies offer insight into drug interactions facilitating profound insight into therapeutic dynamics, paving the way for enhanced medical research, optimizing patient care, and driving informed decision-making processes.
In vitro combination studies provide an in-depth analysis of cellular interactions. They illuminate drug synergy or antagonism, serving as an essential tool for crafting enhanced therapeutic strategies and optimized drug formulations.
Our AI-prediction platform excels in predicting drug responses, interactions, and potential outcomes. Utilizing cutting-edge technology, we accelerate drug development, ensuring a more efficient and effective approach to the development of therapeutic strategies.